BioAge Labs, Inc.
BIOA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$20,171 | -$21,563 | -$12,928 | -$21,129 |
| Dep. & Amort. | $49 | $58 | $37 | $47 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $2,791 | $3,229 | $2,949 | $2,721 |
| Change in WC | $1,227 | -$1,787 | -$7,532 | $13,582 |
| Other Non-Cash | $60 | $94 | $111 | -$359 |
| Operating Cash Flow | -$16,044 | -$19,969 | -$17,363 | -$5,138 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$22 | -$159 | -$426 | -$26 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$12,887 | -$23,982 | -$77,562 | $0 |
| Inv. Sales/Matur. | $25,750 | $8,500 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $12,841 | -$15,641 | -$77,988 | -$26 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1,500 | -$1,500 | -$1,500 | -$1,500 |
| Stock Issued | $0 | $0 | $0 | $27,621 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$44 | $0 | $0 | -$1,219 |
| Financing Cash Flow | -$1,544 | -$1,500 | -$1,500 | $24,902 |
| Forex Effect | -$10 | -$46 | -$12 | $137 |
| Net Chg. in Cash | -$4,757 | -$37,156 | -$96,863 | $19,875 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $220,330 | $257,486 | $354,349 | $334,474 |
| End Cash | $215,573 | $220,330 | $257,486 | $354,349 |
| Free Cash Flow | -$16,066 | -$20,128 | -$17,789 | -$5,164 |